May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Nepafenac Used for the Treatment of Chronic Pseudophakic Cystoid Macular Edema
Author Affiliations & Notes
  • J. A. Clever
    Department of Ophthalmology, Saint Louis University, Saint Louis, Missouri
  • L. Akduman
    Department of Ophthalmology, Saint Louis University, Saint Louis, Missouri
  • Footnotes
    Commercial Relationships J.A. Clever, None; L. Akduman, Commercial Disclosure, R.
  • Footnotes
    Support Grant from Research to Prevent Blindness (RPB)
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 4155. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. A. Clever, L. Akduman; Nepafenac Used for the Treatment of Chronic Pseudophakic Cystoid Macular Edema. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4155.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: We evaluated the efficacy of nepafenac in chronic pseudophakic cystoid macular edema (CME) unresponsive to other topical medications.

Methods:: We reviewed the records of 9 consecutive patients (9 eyes) who were switched to nepafenac for chronic pseudophakic CME. Initial and final best corrected visual acuity (BCVA), initial and final central foveal thickness (CFT) via optical coherence tomography (OCT), and previous and concomitant medications were noted.

Results:: All patients but one received nepafenac alone. One patient used topical prednisolone along with nepafenac. Previous medications discontinued were topical ketorolac, flurbiprofen, and prednisolone. Mean BCVA improved from 20/96 (range: 20/40 to 20/200) to 20/78 (range: 20/25 to 20/200) in a mean follow-up time of 4 months. CFT improved by 22.4% (from 397µ to 308µ). Rechallenge with nepafenac in two patients who recurred resulted in resolution of edema in one month.

Conclusions:: Nepafenac appears to be effective in chronic pseudophakic CME unresponsive to other to topical medications.

Keywords: macula/fovea • cataract 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×